Literature DB >> 1580452

Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering?

W W Stead1.   

Abstract

Recent observations strongly suggest a significant role for genetic factors in innate resistance to infection by Mycobacterium tuberculosis. This relation was discovered in a study of tuberculosis in Arkansas nursing homes and was supported by data from three outbreaks of tuberculosis in two prisons. A person's resistance level was found to correlate with the region of his or her ancestry. Ancestors of person's in the more resistant group tended to derive from densely populated areas and cities rife with tuberculosis, whereas the ancestors of person's in the more susceptible group tended to derive from areas once free of tuberculosis. In accordance with current genetic theory, those persons who are less resistant to tuberculosis would be expected to be more resistant to infections endemic to the region once inhabited by their ancestors. Isolation of the gene previously shown to confer specific innate (nonimmune) resistance to tuberculosis should result in the creation of a more rational approach to increasing the capacity of human macrophages to kill tubercle bacilli without producing a positive tuberculin skin test.

Entities:  

Mesh:

Year:  1992        PMID: 1580452     DOI: 10.7326/0003-4819-116-11-937

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  33 in total

1.  Genetic predisposition to clinical tuberculosis: bridging the gap between simple and complex inheritance.

Authors:  L Abel; J L Casanova
Journal:  Am J Hum Genet       Date:  2000-07-05       Impact factor: 11.025

2.  Tuberculosis in children and adults: two distinct genetic diseases.

Authors:  Alexandre Alcaïs; Claire Fieschi; Laurent Abel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

Review 3.  Genetics and pulmonary medicine. 3. Genetic susceptibility to tuberculosis in human populations.

Authors:  R Bellamy
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

4.  Genetic susceptibility to tuberculosis in Africans: a genome-wide scan.

Authors:  R Bellamy; N Beyers; K P McAdam; C Ruwende; R Gie; P Samaai; D Bester; M Meyer; T Corrah; M Collin; D R Camidge; D Wilkinson; E Hoal-Van Helden; H C Whittle; W Amos; P van Helden; A V Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Cloning and characterization of a second human NRAMP gene on chromosome 12q13.

Authors:  S Vidal; A M Belouchi; M Cellier; B Beatty; P Gros
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

6.  Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model.

Authors:  J Dormans; M Burger; D Aguilar; R Hernandez-Pando; K Kremer; P Roholl; S M Arend; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

7.  Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence.

Authors:  W Chen; R S Baric
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice.

Authors:  D H Brown; J Sheridan; D Pearl; B S Zwilling
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990.

Authors:  S E Buskin; J L Gale; N S Weiss; C M Nolan
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

10.  Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium.

Authors:  C Fayolle; D O'Callaghan; P Martineau; A Charbit; J M Clément; M Hofnung; C Leclerc
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.